Ultralife Corporation
ULBI
$6.94
$0.040.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.42% | 16.24% | 12.94% | 5.86% | 2.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.42% | 16.24% | 12.94% | 5.86% | 2.74% |
| Cost of Revenue | 11.44% | 18.76% | 16.27% | 8.34% | 3.35% |
| Gross Profit | -0.56% | 8.95% | 3.54% | -1.14% | 0.96% |
| SG&A Expenses | 13.35% | 19.86% | 14.51% | 9.09% | 6.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.35% | 19.30% | 16.68% | 9.19% | 4.65% |
| Operating Income | -50.05% | -25.22% | -33.08% | -31.63% | -19.23% |
| Income Before Tax | -261.16% | -201.17% | -78.91% | -64.21% | -45.88% |
| Income Tax Expenses | -282.57% | -229.33% | -69.99% | -49.40% | -36.99% |
| Earnings from Continuing Operations | -254.18% | -192.85% | -80.78% | -67.55% | -48.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 188.78% | 154.64% | 51.43% | -600.00% | -437.93% |
| Net Income | -255.39% | -193.44% | -80.89% | -68.24% | -49.34% |
| EBIT | -50.05% | -25.22% | -33.08% | -31.63% | -19.23% |
| EBITDA | -29.38% | -9.78% | -16.35% | -18.90% | -11.26% |
| EPS Basic | -254.88% | -192.53% | -81.11% | -68.67% | -50.30% |
| Normalized Basic EPS | -58.21% | -36.73% | -54.56% | -44.44% | -28.03% |
| EPS Diluted | -258.26% | -194.08% | -81.95% | -69.17% | -50.06% |
| Normalized Diluted EPS | -57.83% | -36.12% | -54.25% | -44.14% | -28.43% |
| Average Basic Shares Outstanding | 0.21% | 0.53% | 0.93% | 1.50% | 2.06% |
| Average Diluted Shares Outstanding | -0.79% | -0.51% | 0.07% | 1.28% | 2.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |